PressFebruary 23, 2021 PharmaTher Announces Research Collaboration for Microneedle Delivery of Psychedelic Pharmaceuticals
PressFebruary 22, 2021 Awakn Announces Results of the World’s First ‘MDMA in Alcohol Use Disorder’ Trial
PressFebruary 9, 2021 Tryp Therapeutics Plans Phase 2a Eating Disorder Clinical Trial with Dr. Jennifer Miller
PressFebruary 5, 2021 Mindset Files Multiple Final Patent Applications on Its Novel Psilocybin-Inspired Compounds
PressFebruary 3, 2021 Champignon Brands : New Rapid mood Screener (RMS) Screens for Manic Symptoms and Bipolar I Disorder Features to Address Unmet Clinical Need
PressFebruary 2, 2021 MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics
